International Assets Investment Management’s Sarepta Therapeutics SRPT Stock Holding History

International Assets Investment Management’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$79.4K	Sell	4,364 -100	-2%	-$1.89K	﹤0.01%	1166
2026 Q1	$98.8K	Sell	4,464 -310	-6%	-$6K	0.01%	1015
2025 Q4	$103K	Buy	+4,774	New	+$101K	0.01%	1002
2024 Q4	–	Sell	-608	Closed	-$75.9K	–	1775
2024 Q3	$75.9K	Buy	608 +480	+375%	+$66.4K	0.01%	922
2024 Q2	$20.2K	Buy	+128	New	+$16.4K	﹤0.01%	1478
2023 Q2	–	Sell	-118	Closed	-$16.3K	–	940
2023 Q1	$16.3K	Buy	+118	New	+$15.3K	﹤0.01%	815
2021 Q2	–	Sell	-275	Closed	-$30K	–	1707
2021 Q1	$30K	Buy	275 +167	+155%	+$15.4K	﹤0.01%	1140
2020 Q4	$18K	Buy	+108	New	+$16K	﹤0.01%	1211

Other funds holding SRPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

International Assets Investment Management's SRPT Position: Q2 2026 in Review

International Assets Investment Management reduced its Sarepta Therapeutics (SRPT) stake by 2.2% in Q2 2026, selling an estimated $1.89K and leaving 4,364 shares worth $79.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1166.

International Assets Investment Management first reported a position in SRPT in Q4 2020 and has held it in 8 quarters since. The position peaked at $103K in Q4 2025. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

International Assets Investment Management held 4,364 shares of Sarepta Therapeutics worth $79.4K as of Q2 2026.
International Assets Investment Management sold 100 Sarepta Therapeutics shares in Q2 2026, an estimated $1.89K.
Sarepta Therapeutics made up ﹤0.01% of International Assets Investment Management's portfolio in Q2 2026, its #1166 holding.
International Assets Investment Management first reported a position in Sarepta Therapeutics in Q4 2020 and has held it in 8 quarters since.
International Assets Investment Management's Sarepta Therapeutics position peaked at $103K in Q4 2025.
323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.